Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Medtronic; Edwards Lifesciences
• Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Edwards Lifesciences